Using biodegradable patches to treat congenital diaphragmatic hernia
Biodegradable elastic patches for congenital diaphragmatic hernia treatment
This study is testing new stretchy patches made from biodegradable materials to help treat congenital diaphragmatic hernia in babies, aiming to improve healing and reduce complications as the child grows.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Arlington NIH-funded |
| Lab location | 1 site (Arlington, United States) |
| Project ID | NIH-10667413 on NIH RePORTER |
What this research studies
This research focuses on developing biodegradable elastic patches to treat congenital diaphragmatic hernia (CDH), a serious birth defect where abdominal organs move into the chest due to an incomplete diaphragm. The approach involves creating patches that can grow with the child, reducing the risk of complications associated with traditional synthetic materials. By utilizing innovative materials that promote healing and growth, the research aims to improve surgical outcomes for affected children. The project will involve testing these patches in a clinical setting to evaluate their effectiveness and safety.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants and children diagnosed with congenital diaphragmatic hernia requiring surgical intervention.
Not a fit: Patients with congenital diaphragmatic hernia who are not candidates for surgical repair or those with other severe comorbidities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective treatment options for children with congenital diaphragmatic hernia.
How similar studies have performed: Previous research has shown promise in using biodegradable materials for surgical applications, indicating potential success for this novel approach.
Where this research is happening
Arlington, United States
- University of Texas Arlington — Arlington, United States (Active)
Researchers
- Principal investigator: Hong, Yi — University of Texas Arlington
- Study coordinator: Hong, Yi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.